Vivos Therapeutics, Inc. (VVOS) Ownership

$2.34

$0.02 (-0.85%)
Last update: 04:00 PM EST
Day's range
$2.24
Day's range
$2.43

Vivos Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ANSON FUNDS MANAGEMENT LP 05/14/2025 242.58 K $1.04 M   0.00% 2.82%
CUTTER & CO BROKERAGE, INC. 05/01/2025 49.10 K $139.94 K   28.87% 0.57%
COMMONWEALTH EQUITY SERVICES, LLC 05/09/2025 34.00 K $97.00 K   30.77% 0.40%
STATE STREET CORP 05/15/2025 11.82 K $33.69 K   100.00% 0.14%
EWA, LLC 04/22/2025 10.46 K $29.82 K   100.00% 0.12%
MORGAN STANLEY 05/15/2025 1.31 K $3.75 K   1,675.68% 0.02%
GROUP ONE TRADING, L.P. 05/14/2025 228 $650   0.00% 0.00%
RONALD BLUE TRUST, INC. 04/21/2025 160 $456   0.00% 0.00%
BANK OF AMERICA CORP /DE/ 05/15/2025 130 $370   8.33% 0.00%
KOZAK & ASSOCIATES, INC. 04/15/2025 49 $110   0.00% 0.00%
TD WATERHOUSE CANADA INC. 05/09/2025 0 $0   -100.00% 0.00%

Vivos Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 7 institutional investors and hedge funds held shares of Vivos Therapeutics, Inc.. The most heavily invested institutionals were:

Anson Funds Management LP: 242,583

Cutter & CO Brokerage, Inc.: 49,100

COMMONWEALTH EQUITY SERVICES, LLC: 34,000

EWA, LLC: 10,464

Ronald Blue Trust, Inc.: 160

Kozak & Associates, Inc.: 49

6.10% of Vivos Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 336.36 K shares in the last 24 months. This purchase volume represents approximately $787.07 K in transactions.